Country: Միացյալ Թագավորություն
language: անգլերեն
source: VMD (Veterinary Medicines Directorate)
Dichlorophen, Piperazine Citrate
Battle, Hayward & Bower Ltd
QP52AG01
Dichlorophen, Piperazine Citrate
Tablet
AVM-GSL - Authorised Veterinary Medicine – General Sales List
Cats
Anthelmintic
Expired
1995-12-13
Revised: 14 th January 2009 AN: 02297/2007 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dual Action Worming Tablets for Cats 2. QUALITATIVE AND QUANTIITATIVE COMPOSITION Each roundworm tablet contains: ACTIVE SUBSTANCE(S) MG Piperazine Citrate BP 500 Each tapeworm tablet contains: ACTIVE SUBSTANCE MG Dichlorophen 500 EXCIPIENTS Amaranth (E123) 0.055 For a full list of excipients see section 6.1 3. PHARMACEUTICAL FORM. Tablet Roundworm- circular, biconvex, white tablets engraved on one side with a breakline Tapeworm- circular, biconvex, pink tablets engraved on one side with a breakline. 4. CLINICAL PARTICULARS. 4.1 TARGET SPECIES; Cats and Kittens 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES; For the treatment of roundworms (Ascarids) and tapeworms in cats and kittens over 6 months old. 4.3 CONTRA INDICATION; Do not give Roundworm tablets and Tapeworm tablets on the same day. Do not repeat the treatment if vomiting occurs shortly after dosing. Do not administer to animals weighing less than 1.25Kg or under 6 months of age. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES; Cats are particularly susceptible to CNS side effects of phenols which include vomiting, depression and incoordination. Revised: 14 th January 2009 AN: 02297/2007 4.5 SPECIAL PRECAUTIONS FOR USE INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO THE ANIMALS; I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Consult a veterinary surgeon before dosing animals with a history of epilepsy or severe renal dysfunction. Do not use if your pet is sick or recovering from an illness It is important to establish the bodyweight of the animal accurately before treatment to ensure correct dosage administration. Animals weighing less than 1.25Kg should be treated with a suitable product authorised for this purpose. Do not exceed the recommended dosage. II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS Ingredients in this product are known to read_full_document